Contribution of mutations in genes of the surfactant system to idiopathic interstitial pneumonia (IIP)
N. Nathan (Paris, France), M. Legendre (Paris, France), E. Filhol-Blin (Paris, France), R. Borie (Paris, France), D. Bouvry (Bobigny, France), M. Afanetti (Nice, France), K. Ahmad (Lyon, France), J. Albuisson (Paris, France), N. Allou (Saint Denis de La Réunion, France), C. Bailly (Nice, France), K. Borensztajn (Paris, France), A. Butt (Paris, France), B. Copin (Paris, France), A. Coulomb L'Hermine (Paris, France), B. Crestani (Paris, France), J. Dalphin (Besancon, France), M. Dalphin (Besancon, France), F. Dastot Le Moal (Paris, France), C. Delacourt (Paris, France), B. Delaisi (Paris, France), A. Deschildre (Lille, France), P. De Vuyst (Brussels, Belgium), B. Diot (Tours, France), C. Dromer (Bordeaux, France), J. Dubus (Marseille, France), P. Duquesnoy (Paris, France), L. Giovannini-Chami (Nice, France), V. Giraud (Bouogne Billancourt, France), C. Gomez (Marseille, France), A. Gondouin (Besançon, France), L. Gouya (Colombes, France), A. Hadchouel (Paris, France), S. Hirschi (Strasbourg, France), V. Houdouin (Paris, France), D. Israel Biet (Paris, France), C. Kannengiesser (Paris, France), C. Lefevre (Paris, France), E. Manali (Athens, Greece), S. Marchand-Adam (Tours, France), C. Marguet (Rouen, France), J. Naccache (Paris, France), V. Nau (Paris, France), H. Nunes (Bobigny, France), O. O'Connell (Dublin, Ireland), K. O'Reilly (Dublin, Ireland), S. Papiris (Athens, Greece), C. Picard (Suresnes, France), G. Prevot (Toulouse, France), P. Reix (Lyon, France), M. Reynaud-Gaubert (Marseille, France), E. Rivaud (Suresnes, France), E. Schaefer (Strasbourg, France), A. Tatopoulos (Nancy, France), J. Traclet (Lyon, France), F. Troussier (Angers, France), D. Valeyre (Bobigny, France), V. Cottin (Lyon, France), A. Clement (Paris, France), S. Amselem (Paris, France)
Source: International Congress 2018 – Clinical news in idiopathic interstitial pneumonias
Session: Clinical news in idiopathic interstitial pneumonias
Session type: Oral Presentation
Number: 547
Disease area: Interstitial lung diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Nathan (Paris, France), M. Legendre (Paris, France), E. Filhol-Blin (Paris, France), R. Borie (Paris, France), D. Bouvry (Bobigny, France), M. Afanetti (Nice, France), K. Ahmad (Lyon, France), J. Albuisson (Paris, France), N. Allou (Saint Denis de La Réunion, France), C. Bailly (Nice, France), K. Borensztajn (Paris, France), A. Butt (Paris, France), B. Copin (Paris, France), A. Coulomb L'Hermine (Paris, France), B. Crestani (Paris, France), J. Dalphin (Besancon, France), M. Dalphin (Besancon, France), F. Dastot Le Moal (Paris, France), C. Delacourt (Paris, France), B. Delaisi (Paris, France), A. Deschildre (Lille, France), P. De Vuyst (Brussels, Belgium), B. Diot (Tours, France), C. Dromer (Bordeaux, France), J. Dubus (Marseille, France), P. Duquesnoy (Paris, France), L. Giovannini-Chami (Nice, France), V. Giraud (Bouogne Billancourt, France), C. Gomez (Marseille, France), A. Gondouin (Besançon, France), L. Gouya (Colombes, France), A. Hadchouel (Paris, France), S. Hirschi (Strasbourg, France), V. Houdouin (Paris, France), D. Israel Biet (Paris, France), C. Kannengiesser (Paris, France), C. Lefevre (Paris, France), E. Manali (Athens, Greece), S. Marchand-Adam (Tours, France), C. Marguet (Rouen, France), J. Naccache (Paris, France), V. Nau (Paris, France), H. Nunes (Bobigny, France), O. O'Connell (Dublin, Ireland), K. O'Reilly (Dublin, Ireland), S. Papiris (Athens, Greece), C. Picard (Suresnes, France), G. Prevot (Toulouse, France), P. Reix (Lyon, France), M. Reynaud-Gaubert (Marseille, France), E. Rivaud (Suresnes, France), E. Schaefer (Strasbourg, France), A. Tatopoulos (Nancy, France), J. Traclet (Lyon, France), F. Troussier (Angers, France), D. Valeyre (Bobigny, France), V. Cottin (Lyon, France), A. Clement (Paris, France), S. Amselem (Paris, France). Contribution of mutations in genes of the surfactant system to idiopathic interstitial pneumonia (IIP). 547
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Surfactant protein C mutations in sporadic forms of idiopathic interstitial pneumonias Source: Eur Respir J 2007; 29: 134-137 Year: 2007
Non-IPF idiopathic interstitial pneumonia (IIPs) Source: ERS Course 2016 Year: 2016
Clinical-radiographic-pathologic diagnosis in idiopathic interstitial pneumonia (IIP) Source: Eur Respir J 2002; 20: Suppl. 38, 61s Year: 2002
ProSP-B as a possible biomarker in idiopathic interstitial pneumonias (ILD) Source: Annual Congress 2012 - Diffuse parenchymal lung disease pathogenesis, biomarkers, therapy and new entities Year: 2012
Clinical categorisation of idiopathic interstitial pneumonia Source: Annual Congress 2005 - Idiopathic pulmonary fibrosis: new concepts in its pathogenesis and management Year: 2005
Functional assessment of newly identified SFTPA1 and SFTPA2 mutations in patients with idiopathic interstitial pneumonia (IIP) and lung cancer Source: International Congress 2018 – New insights in rare diffuse parenchymal lung diseases (DPLDs) in adults and children Year: 2018
Histology and pathogenesis of usual interstitial pneumonia (UIP) versus nonspecific interstitial pneumonia (NSIP): progressive remodeling or resolution and healing? Source: Annual Congress 2006 - Usual interstitial pneumonia (UIP) and nonspecific interstitial pneumonia (NSIP), idiopathic or not: new concepts in diagnosis and treatment Year: 2006
Cykine/receptor inflammatory profile in different types of idiopathic intestitial pneumonias (IIPs). Key role of Fas Ligand recruvation in idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease Year: 2010
Analysis of small airway function in patients with idiopathic interstitial pneumonia Source: Annual Congress 2008 - Clinical aspects of interstitial lung disease Year: 2008
Interstitial lung disease in a baby with a de novo mutation in the SFTPC gene Source: Eur Respir J 2004; 24: 30-39 Year: 2004
Idiopathic pulmonary fibrosis (IPF) and idiopathic nonspecific interstitial pneumonia (NSIP): what treatment and for whom? Source: Annual Congress 2006 - Usual interstitial pneumonia (UIP) and nonspecific interstitial pneumonia (NSIP), idiopathic or not: new concepts in diagnosis and treatment Year: 2006
The classification, natural history and radiological/histological appearance of idiopathic pulmonary fibrosis and the other idiopathic interstitial pneumonias Source: Eur Respir Rev 2008; 17: 108-115 Year: 2008
Clinical significance of histological classification of idiopathic interstitial pneumonia Source: Eur Respir J 2002; 19: 275-283 Year: 2002
Small airways structural alterations in usual interstitial pneumonia (UIP), non-specific interstitial pneumonia (NSIP), hypersensitivity pneumonia (HP) and chronic bronchiolitis (CB) Source: Eur Respir J 2006; 28: Suppl. 50, 308s Year: 2006
Diagnostic mistakes in patients with idiopathic interstitial pneumonias (IIP) Source: Annual Congress 2009 - Various backgrounds in diffuse parenchymal lung disease Year: 2009
Surfactant proteins in interstitial pneumonia Source: Annual Congress 2005 - Lung-specific serum markers for interstitial lung diseases Year: 2005
Enhanced apoptosis of alveolar lymphocytes (AL), but not macrophages (AM) in interstitial idiopathic pneumonias (IIPs). Special attention to idiopathic pulmonary fibrosis (IPF) results Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease Year: 2010
Differences in pulmonary function tests (PFTs) in patients with usual interstitial pneumonia (UIP) and nonspecific interstitial pneumonia (NSIP) Source: Eur Respir J 2001; 18: Suppl. 33, 260s Year: 2001
Idiopathic interstitial pneumonia (IIP) - optimal timing for initiating treatment Source: Eur Respir J 2004; 24: Suppl. 48, 535s Year: 2004
Genetics variants in familial interstitial pneumonia and progressive fibrosing interstitial lung disease (PF-ILD) Source: Virtual Congress 2021 – Genetics and translational aspects of idiopathic pulmonary fibrosis Year: 2021